Department of Health and Human Services November 26, 2013 – Federal Register Recent Federal Regulation Documents

Renewal of the Advisory Committee on the Maternal, Infant and Early Childhood Home Visiting Program Evaluation
Document Number: 2013-28324
Type: Notice
Date: 2013-11-26
Agency: Department of Health and Human Services, Health Resources and Services Administration, Administration for Children and Families
ACF and HRSA announce the renewal of the Advisory Committee on the Maternal, Infant and Early Childhood Home Visiting Program Evaluation to provide advice to the Secretary of Health and Human Services (``the Secretary'') on the design, plan, progress, and findings of the evaluation required under the Act.
Agency Forms Undergoing Paperwork Reduction Act Review
Document Number: 2013-28297
Type: Notice
Date: 2013-11-26
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Proposed Data Collections Submitted for Public Comment and Recommendations
Document Number: 2013-28296
Type: Notice
Date: 2013-11-26
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Patient Safety Organizations: Voluntary Relinquishment From GE-PSO
Document Number: 2013-28284
Type: Notice
Date: 2013-11-26
Agency: Agency for Healthcare Research and Quality, Department of Health and Human Services
The Patient Safety and Quality Improvement Act of 2005 (Patient Safety Act), Public Law 109-41, 42 U.S.C. 299b-21-b-26, provides for the formation of Patient Safety Organizations (PSOs), which collect, aggregate, and analyze confidential information regarding the quality and safety of health care delivery. The Patient Safety and Quality Improvement Final Rule (Patient Safety Rule), 42 CFR part 3, authorizes AHRQ, on behalf of the Secretary of HHS, to list as a PSO an entity that attests that it meets the statutory and regulatory requirements for listing. A PSO can be ``delisted'' by the Secretary if it is found no longer to meet the requirements of the Patient Safety Act and Patient Safety Rule, or when a PSO chooses to voluntarily relinquish its status as a PSO for any reason. AHRQ has accepted a notification of voluntary relinquishment from the GE-PSO of its status as a PSO, and has delisted the PSO accordingly.
Patient Safety Organizations: Voluntary Relinquishment From Morgridge Institute for Research PSO
Document Number: 2013-28283
Type: Notice
Date: 2013-11-26
Agency: Agency for Healthcare Research and Quality, Department of Health and Human Services
The Patient Safety and Quality Improvement Act of 2005 (Patient Safety Act), Public Law 109-41, 42 U.S.C. 299b-21-b-26, provides for the formation of Patient Safety Organizations (PSOs), which collect, aggregate, and analyze confidential information regarding the quality and safety of health care delivery. The Patient Safety and Quality Improvement Final Rule (Patient Safety Rule), 42 CFR Part 3, authorizes AHRQ, on behalf of the Secretary of HHS, to list as a PSO an entity that attests that it meets the statutory and regulatory requirements for listing. A PSO can be ``delisted'' by the Secretary if it is found no longer to meet the requirements of the Patient Safety Act and Patient Safety Rule, or when a PSO chooses to voluntarily relinquish its status as a PSO for any reason. AHRQ has accepted a notification of voluntary relinquishment from Morgridge Institute for Research PSO of its status as a PSO, and has delisted the PSO accordingly.
Review of Proposed Changes with ICD-10-CM/PCS; Conversion of Quality IndicatorsTM
Document Number: 2013-28282
Type: Notice
Date: 2013-11-26
Agency: Agency for Healthcare Research and Quality, Department of Health and Human Services
The Agency for Healthcare Research and Quality (AHRQ) seeks comments on the proposed conversion of the AHRQ Quality IndicatorsTM to ``International Classification of Diseases, 10th Edition, Clinical Modification/Procedure Coding System'' (ICD-10- CM and ICD-10-PCS) codes. These changes would be applicable to hospital discharges occurring on or after October 1, 2014. The proposed ICD-10- CM/PCS codes are posted on the AHRQ QI Web site for review at: http:// www.qualityindicators.ahrq.gov/icd10/default.aspx
Proposed Data Collections Submitted for Public Comment and Recommendations
Document Number: 2013-28281
Type: Notice
Date: 2013-11-26
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Proposed Data Collections Submitted for Public Comment and Recommendations
Document Number: 2013-28280
Type: Notice
Date: 2013-11-26
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Patient Safety Organizations: Delisting for Cause for Leadership Triad
Document Number: 2013-28279
Type: Notice
Date: 2013-11-26
Agency: Agency for Healthcare Research and Quality, Department of Health and Human Services
AHRQ has delisted Leadership Triad due to its failure to correct a deficiency. The Patient Safety and Quality Improvement Act of 2005 (Patient Safety Act), Public Law 109-41, 42 U.S.C. 299b-21b-26, authorizes the listing of Patient Safety Organizations (PSOs), which are entities or component organizations whose mission and primary activity is to conduct activities to improve patient safety and the quality of health care delivery. HHS issued the Patient Safety and Quality Improvement Final Rule (Patient Safety Rule) to implement the Patient Safety Act. AHRQ administers the provisions of the Patient Safety Act and Patient Safety Rule relating to the listing and operation of PSOs.
Center for Scientific Review; Notice of Closed Meetings
Document Number: 2013-28267
Type: Notice
Date: 2013-11-26
Agency: Department of Health and Human Services, National Institutes of Health
Office of the Director, National Institutes of Health; Notice of Meeting
Document Number: 2013-28266
Type: Notice
Date: 2013-11-26
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of General Medical Sciences; Amended Notice of Meeting
Document Number: 2013-28265
Type: Notice
Date: 2013-11-26
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of General Medical Sciences; Notice of Closed Meeting
Document Number: 2013-28264
Type: Notice
Date: 2013-11-26
Agency: Department of Health and Human Services, National Institutes of Health
Center for Scientific Review; Amended Notice of Meeting
Document Number: 2013-28263
Type: Notice
Date: 2013-11-26
Agency: Department of Health and Human Services, National Institutes of Health
Withdrawal of Approval of New Animal Drug Applications; Arsanilic Acid
Document Number: 2013-28256
Type: Rule
Date: 2013-11-26
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect the withdrawal of approval of a new animal drug application (NADA) for an arsanilic acid Type A medicated article at the sponsor's request because the product is no longer manufactured or marketed.
Withdrawal of Approval of New Animal Drug Applications; Arsanilic Acid
Document Number: 2013-28255
Type: Notice
Date: 2013-11-26
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is withdrawing approval of a new animal drug application (NADA) for an arsanilic acid Type A medicated article at the sponsor's request because the product is no longer manufactured or marketed.